Publikationen, an denen er mitarbeitet Alberto Goday Arno (21)

2023

  1. Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

    Biomedicine and Pharmacotherapy, Vol. 161

  2. Coronavirus disease 2019 is associated with long-term depressive symptoms in Spanish older adults with overweight/obesity and metabolic syndrome

    Psychological Medicine

  3. Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort(Front. Endocrinol., (2022), 13, (868795), 10.3389/fendo.2022.868795)

    Frontiers in Endocrinology

  4. How Did the COVID-19 Lockdown Pandemic Affect the Depression Symptomatology in Mediterranean Older Adults with Metabolic Syndrome?

    Depression and Anxiety, Vol. 2023

  5. Intensive Weight-Loss Lifestyle Intervention Using Mediterranean Diet and COVID-19 Risk in Older Adults: Secondary Analysis of PREDIMED-Plus Trial

    Journal of Nutrition, Health and Aging, Vol. 27, Núm. 12, pp. 1162-1167

2022

  1. Factors associated with successful dietary changes in an energy-reduced Mediterranean diet intervention: a longitudinal analysis in the PREDIMED-Plus trial

    European Journal of Nutrition, Vol. 61, Núm. 3, pp. 1457-1475

  2. One-year changes in fruit and vegetable variety intake and cardiometabolic risk factors changes in a middle-aged Mediterranean population at high cardiovascular risk

    European Journal of Clinical Nutrition, Vol. 76, Núm. 10, pp. 1393-1402

  3. Prospective associations between a priori dietary patterns adherence and kidney function in an elderly Mediterranean population at high cardiovascular risk

    European Journal of Nutrition, Vol. 61, Núm. 6, pp. 3095-3108

  4. Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort

    Frontiers in Endocrinology, Vol. 13

2021

  1. Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population

    European Journal of Nutrition, Vol. 60, Núm. 5, pp. 2381-2396

  2. Consumption of caffeinated beverages and kidney function decline in an elderly Mediterranean population with metabolic syndrome

    Scientific Reports, Vol. 11, Núm. 1

  3. Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function: A Randomized Controlled Trial

    American Journal of Nephrology, Vol. 52, Núm. 1, pp. 45-58

  4. Variety in fruits and vegetables, diet quality and lifestyle in an older adult mediterranean population

    Clinical Nutrition, Vol. 40, Núm. 4, pp. 1510-1518

2020

  1. Carbohydrate quality changes and concurrent changes in cardiovascular risk factors: A longitudinal analysis in the PREDIMED-Plus randomized trial

    American Journal of Clinical Nutrition, Vol. 111, Núm. 2, pp. 291-306

  2. Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study

    European Journal of Nutrition, Vol. 59, Núm. 5, pp. 2195-2206

  3. Dietary quality changes according to the preceding maximum weight: A longitudinal analysis in the predimed-plus randomized trial

    Nutrients, Vol. 12, Núm. 10, pp. 1-15

2019

  1. Cohort profile: Design and methods of the PREDIMED-Plus randomized trial

    International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o

  2. Effect of a Nutritional and Behavioral Intervention on Energy-Reduced Mediterranean Diet Adherence among Patients with Metabolic Syndrome: Interim Analysis of the PREDIMED-Plus Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 322, Núm. 15, pp. 1486-1499

  3. Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and exercise on weight loss and cardiovascular risk factors: One-year results of the PREDIMED-Plus trial

    Diabetes Care, Vol. 42, Núm. 5, pp. 777-788

2018

  1. Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial

    PLoS ONE, Vol. 13, Núm. 6